Replies to post #343556 on Avid Bioservices Inc (CDMO)

[Protector]

Preciouslife1, do yo have a time-frame in mind in relation to :

An opportunity to either be bought out at an accelerated price, and or the share price to even triple or quadruple from here based upon that high barrier to entry and low share float!

Let's forget about the first part of the sentence because that nobody can reasonably now. Being bought could be tomorrow or in 10 years.

But the bold-face part of the text is production and capacity based. CDMO has a good reputation, a large number of lab-production related awards. Very modern labs with mostly reusable reactors, forward processes, etc. And with the Orange County we are ahead on the market for the smaller players in that segment of which only 1 needs to be successful after research to hit the jackpot.

We are in Q1/2023, so first fruits of the now ready labs should be coming about Q4/2023. I have hereby assumed that the FDA facility and process approvals will make us loose time. The later are (should be) paid for by all those customers in our back-log, which proove market acceptance of CDMO's operations.

So, when do you see the PPS moving up, consistently and to stay up?

AIMO